Detalles de la búsqueda
1.
A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients with EGFR-mutated, MET-amplified advanced non-small-cell lung cancer.
Invest New Drugs
; 39(2): 477-487, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33052556
2.
Survey and analysis of the nutritional status in hospitalized patients with malignant gastric tumors and its influence on the quality of life.
Support Care Cancer
; 28(1): 373-380, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31049672
3.
A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).
BMC Cancer
; 17(1): 462, 2017 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28673332
4.
A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung.
BMC Cancer
; 14: 684, 2014 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25239521
5.
Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study.
J Cancer Res Clin Oncol
; 149(12): 10771-10780, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37316692
6.
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study.
Cancer Cell
; 39(9): 1279-1291.e3, 2021 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34388377
7.
[Effects of vinorelbine on apoptosis and expression of telomerase activity in human lung adenocarcinoma cells in vitro].
Zhonghua Zhong Liu Za Zhi
; 32(10): 743-7, 2010 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-21163063
8.
GEMSTONE-301: a phase III clinical trial of CS1001 as consolidation therapy in patients with locally advanced/unresectable (stage III) non-small cell lung cancer (NSCLC) who did not have disease progression after prior concurrent/sequential chemoradiotherapy.
Transl Lung Cancer Res
; 9(5): 2008-2015, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33209620
9.
Inhibition of c-MET upregulates PD-L1 expression in lung adenocarcinoma.
Am J Cancer Res
; 10(2): 564-571, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32195027
10.
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma.
Front Oncol
; 10: 1568, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33042801
11.
A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002).
Eur J Cancer
; 109: 183-191, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30739019
12.
Factors associated with gene aberration test status and treatment decision in patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer: A multicenter survey in China (CTONG 1506).
Lung Cancer
; 123: 7-13, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30089597
13.
[Establishment of a multi drug-resistant human lung adenocarcinoma cell line and biological characteristics there of].
Zhonghua Yi Xue Za Zhi
; 87(13): 924-6, 2007 Apr 03.
Artículo
en Zh
| MEDLINE | ID: mdl-17650408
14.
A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel.
ESMO Open
; 2(Suppl 1): e000174, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28848676
15.
MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas.
Oncol Rep
; 33(5): 2599-605, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25738322
16.
Erlotinib plus capecitabine as first-line treatment for older Chinese patients with advanced adenocarcinoma of the lung (C-TONG0807): an open-label, single arm, multicenter phase II study.
Medicine (Baltimore)
; 94(2): e249, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25590835
17.
A multicenter phase II study of sorafenib monotherapy in clinically selected patients with advanced lung adenocarcinoma after failure of EGFR-TKI therapy (Chinese Thoracic Oncology Group, CTONG 0805).
Lung Cancer
; 83(3): 369-73, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24440279
18.
Significance of survivin expression: Prognostic value and survival in stage III non-small cell lung cancer.
Exp Ther Med
; 3(6): 983-988, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22970003
19.
Multidrug resistance-associated protein 3 and Bcl-2 contribute to multidrug resistance by vinorelbine in lung adenocarcinoma.
Int J Mol Med
; 28(6): 953-60, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21874222
20.
Significance of CXCR4, phosphorylated STAT3 and VEGF-A expression in resected non-small cell lung cancer.
Exp Ther Med
; 2(3): 517-522, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22977534